vs
IRONWOOD PHARMACEUTICALS INC(IRWD)与KKR Real Estate Finance Trust Inc.(KREF)财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是KKR Real Estate Finance Trust Inc.的1.8倍($47.7M vs $25.8M),IRONWOOD PHARMACEUTICALS INC净利率更高(-4.8% vs -101.7%,领先97.0%),KKR Real Estate Finance Trust Inc.同比增速更快(-26.6% vs -47.3%),过去两年KKR Real Estate Finance Trust Inc.的营收复合增速更高(-18.8% vs -20.2%)
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台,主要发起、收购并管理优先担保商业地产贷款组合,抵押物多为美国各地的优质机构级商业地产,通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
IRWD vs KREF — 直观对比
营收规模更大
IRWD
是对方的1.8倍
$25.8M
营收增速更快
KREF
高出20.7%
-47.3%
净利率更高
IRWD
高出97.0%
-101.7%
两年增速更快
KREF
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $47.7M | $25.8M |
| 净利润 | $-2.3M | $-26.2M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | -105.1% |
| 净利率 | -4.8% | -101.7% |
| 营收同比 | -47.3% | -26.6% |
| 净利润同比 | -200.9% | -229.6% |
| 每股收益(稀释后) | $0.01 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRWD
KREF
| Q4 25 | $47.7M | $25.8M | ||
| Q3 25 | $122.1M | $25.3M | ||
| Q2 25 | $85.2M | $30.2M | ||
| Q1 25 | $41.1M | $31.3M | ||
| Q4 24 | $90.5M | $35.1M | ||
| Q3 24 | $91.6M | $37.0M | ||
| Q2 24 | $94.4M | $40.4M | ||
| Q1 24 | $74.9M | $39.1M |
净利润
IRWD
KREF
| Q4 25 | $-2.3M | $-26.2M | ||
| Q3 25 | $40.1M | $13.8M | ||
| Q2 25 | $23.6M | $-29.7M | ||
| Q1 25 | $-37.4M | $-4.9M | ||
| Q4 24 | $2.3M | $20.3M | ||
| Q3 24 | $3.6M | $-7.4M | ||
| Q2 24 | $-860.0K | $25.8M | ||
| Q1 24 | $-4.2M | $-3.1M |
营业利润率
IRWD
KREF
| Q4 25 | 14.3% | -105.1% | ||
| Q3 25 | 61.8% | 50.4% | ||
| Q2 25 | 53.2% | -101.3% | ||
| Q1 25 | -70.7% | -18.3% | ||
| Q4 24 | 34.8% | 55.8% | ||
| Q3 24 | 28.0% | -19.6% | ||
| Q2 24 | 26.5% | 63.3% | ||
| Q1 24 | 14.7% | -8.7% |
净利率
IRWD
KREF
| Q4 25 | -4.8% | -101.7% | ||
| Q3 25 | 32.8% | 54.4% | ||
| Q2 25 | 27.7% | -98.5% | ||
| Q1 25 | -90.9% | -15.5% | ||
| Q4 24 | 2.5% | 57.7% | ||
| Q3 24 | 4.0% | -20.0% | ||
| Q2 24 | -0.9% | 63.9% | ||
| Q1 24 | -5.6% | -7.9% |
每股收益(稀释后)
IRWD
KREF
| Q4 25 | $0.01 | $-0.49 | ||
| Q3 25 | $0.23 | $0.12 | ||
| Q2 25 | $0.14 | $-0.53 | ||
| Q1 25 | $-0.23 | $-0.15 | ||
| Q4 24 | $0.03 | $0.22 | ||
| Q3 24 | $0.02 | $-0.19 | ||
| Q2 24 | $-0.01 | $0.29 | ||
| Q1 24 | $-0.03 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-261.8M | $1.2B |
| 总资产 | $396.9M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IRWD
KREF
| Q4 25 | $215.5M | $84.6M | ||
| Q3 25 | $140.4M | $204.1M | ||
| Q2 25 | $92.9M | $107.7M | ||
| Q1 25 | $108.5M | $106.4M | ||
| Q4 24 | $88.6M | $104.9M | ||
| Q3 24 | $88.2M | $108.8M | ||
| Q2 24 | $105.5M | $107.2M | ||
| Q1 24 | $121.5M | $106.5M |
总债务
IRWD
KREF
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
股东权益
IRWD
KREF
| Q4 25 | $-261.8M | $1.2B | ||
| Q3 25 | $-264.2M | $1.2B | ||
| Q2 25 | $-308.2M | $1.2B | ||
| Q1 25 | $-334.1M | $1.3B | ||
| Q4 24 | $-301.3M | $1.3B | ||
| Q3 24 | $-311.3M | $1.4B | ||
| Q2 24 | $-321.7M | $1.4B | ||
| Q1 24 | $-330.5M | $1.4B |
总资产
IRWD
KREF
| Q4 25 | $396.9M | $6.5B | ||
| Q3 25 | $396.1M | $6.5B | ||
| Q2 25 | $342.9M | $6.8B | ||
| Q1 25 | $327.2M | $6.6B | ||
| Q4 24 | $350.9M | $6.4B | ||
| Q3 24 | $389.5M | $6.8B | ||
| Q2 24 | $395.6M | $7.1B | ||
| Q1 24 | $438.8M | $7.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $74.6M | $72.3M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | — |
| 自由现金流率自由现金流/营收 | 156.3% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $127.0M | — |
8季度趋势,按日历期对齐
经营现金流
IRWD
KREF
| Q4 25 | $74.6M | $72.3M | ||
| Q3 25 | $47.6M | $18.5M | ||
| Q2 25 | $-15.1M | $21.1M | ||
| Q1 25 | $20.0M | $15.9M | ||
| Q4 24 | $15.2M | $132.6M | ||
| Q3 24 | $9.9M | $49.1M | ||
| Q2 24 | $33.5M | $30.6M | ||
| Q1 24 | $45.0M | $34.5M |
自由现金流
IRWD
KREF
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
自由现金流率
IRWD
KREF
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
资本支出强度
IRWD
KREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率
IRWD
KREF
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 1.34× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | 6.54× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图